Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis of 1-substituted phenyl-4-substituted phenyl-5-(2-hydroxyl substituted benzyl) amino-1,2,3-triazole compounds offering high yield and green chemistry benefits for pharmaceutical manufacturing.
Patent CN1025852C details a novel route for quinolone intermediates. Discover cost-effective synthesis and scalable manufacturing solutions for complex diazabicyclic compounds.
Patent CN110003061B reveals a novel iron-catalyzed direct amination method. This technology offers significant cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Novel iridium catalyst enables anti-Markovnikov hydroamination. Enhances yield and stability for pharmaceutical intermediate manufacturing supply chains.
Novel two-step method for Rosuvastatin intermediate offers high yield and reduced environmental impact for pharmaceutical manufacturing supply chains.
Patent CN1077565C reveals a robust Zr-Ni-Cu-Mo catalyst for amino alcohol amination, offering superior selectivity and supply chain stability for pharma intermediates.
Patent CN115232059A reveals a green catalytic route for 6,6-dimethyl-3-azabicyclo[3.1.0]hexane, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN1310871C reveals gas phase amination breakthrough. Achieve higher purity and continuous production for reliable polymer synthesis additives supply chains.
Patent CN88101658A reveals a Ni-Ru-M catalyst for high-selectivity reductive amination, offering cost-effective amine production and supply chain stability.
Novel catalytic amination route for Nevirapine intermediate offers high yield and mild conditions. Reduces manufacturing complexity and ensures supply chain stability for global pharmaceutical partners.
Patent CN110483574B discloses high triplet energy OLED host materials. Discover cost-effective synthesis and supply chain advantages for next-gen displays.
Novel PEG400 catalyzed method enhances Propacetamol Hydrochloride purity and yield. Reliable pharmaceutical intermediates supplier offering cost reduction and scalable production solutions.
Discover patented high-yield synthesis for o-trifluoromethylaniline. Enhanced conversion rates and solvent recycling offer significant supply chain and cost advantages for global buyers.
Patent CN103665032B reveals a high-yield Glufosinate ammonium process. Discover cost reduction in herbicide manufacturing and scalable supply chain solutions.
Patent CN110156816B details a novel synthesis route for tetrahydropyrazolopiperazine compounds, offering improved yield and synergistic anticancer potential for pharmaceutical supply chains.
Novel nitration-bromination-deamination route for 2-bromo-3-fluorobenzoic acid. Cost-effective, scalable pharma intermediate manufacturing with high purity.
Patent CN116514703A reveals a continuous fixed-bed hydrogenation method for N-Boc-4-dimethylaminopiperidone, offering high purity and reduced waste for pharmaceutical supply chains.
Novel synthesis of planar pyrazolo triazine energetic molecules via malononitrile cyclization. Offers superior thermal stability and scalable manufacturing for advanced energetic materials.
Patent CN105906513A reveals high-yield trifluoroethylamine production. Achieve 99.5% purity with simplified amination for cost-effective pharmaceutical intermediate manufacturing.
Novel one-pot method for lapatinib improves yield and purity, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.